Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News and Views
Nature Immunology 9, 1205–1206 (1 November 2008) | doi:10.1038/ni1108-1205
Cancer exploiting complement: a clue or an exception?
&
Abstract
Treatments aimed at boosting the immune response to cancer date back to the late nineteenth century, when New York surgeon William Coley recognized that tumor regression could follow certain suppurative infections. He developed a crude therapy based on a patient's own bacterial flora, which met with some sporadic success.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
